Use of the metallothionein promoter-human growth hormone-releasing hormone (GHRH) mouse to identify regulatory pathways that suppress pituitary somatotrope hyperplasia and adenoma formation due to GHRH-receptor hyperactivation.
Endocrinology., Jul;150(7):3177-85 (2009)
Normal physiology of hypothalamic pituitary regulation.
Endocrinol. Metab. Clin. North Am., Mar;37(1):1-22, vii (2008)
Pulsatile secretion of growth hormone (GH) persists during continuous stimulation by CJC-1295, a long-acting GH-releasing hormone analog.
J. Clin. Endocrinol. Metab., Dec;91(12):4792-7 (2006)
Pituitary tumor enlargement in two patients with acromegaly during pegvisomant therapy.
Pituitary., 10(3):283-9 (2007)
The empty sella.
Pediatr Endocrinol Rev., Jun;4(4):335-42 (2007)
Expression analysis of hypothalamic and pituitary components of the growth hormone axis in fasted and streptozotocin-treated neuropeptide Y (NPY)-intact (NPY+/+) and NPY-knockout (NPY-/-) mice.
Neuroendocrinology., 81(6):360-71 (2005)
Tumor deletion mapping on chromosome 11q13 in eight families with isolated familial somatotropinoma and in 15 sporadic somatotropinomas.
J. Clin. Endocrinol. Metab., Dec;90(12):6580-7 (2005)
Isolated familial somatotropinomas: clinical and genetic considerations.
Trans. Am. Clin. Climatol. Assoc., 114:165-77 (2003)
Growth Horm. IGF Res., Jun;14 Suppl A:S90-6 (2004)
Isolated familial somatotropinoma.
Pituitary., 7(2):95-101 (2004)
Growth hormone-releasing hormone and pituitary somatotrope proliferation.
Minerva Endocrinol., Dec;27(4):277-85 (2002)
The growth hormone (GH)-axis of GH receptor/binding protein gene-disrupted and metallothionein-human GH-releasing hormone transgenic mice: hypothalamic neuropeptide and pituitary receptor expression in the absence and presence of GH feedback.
Endocrinology., Mar;142(3):1117-23 (2001)
The effect of GHRH on somatotrope hyperplasia and tumor formation in the presence and absence of GH signaling.
Endocrinology., Sep;142(9):3764-73 (2001)
Growth hormone-releasing hormone and pituitary development, hyperplasia and tumorigenesis.
Trends Endocrinol. Metab., Sep;13(7):299-303 (2002)
Hypothalamic/pituitary-axis of the spontaneous dwarf rat: autofeedback regulation of growth hormone (GH) includes suppression of GH releasing-hormone receptor messenger ribonucleic acid.
Endocrinology., Aug;139(8):3554-60 (1998)
Growth hormone-dependent regulation of pituitary GH secretagogue receptor (GHS-R) mRNA levels in the spontaneous dwarf Rat.
Neuroendocrinology., Nov;68(5):312-8 (1998)
Loss of heterozygosity on chromosome 11q13 in two families with acromegaly/gigantism is independent of mutations of the multiple endocrine neoplasia type I gene.
J. Clin. Endocrinol. Metab., Jan;84(1):249-56 (1999)
Growth hormone-releasing hormone receptor (GHRH-R) and growth hormone secretagogue receptor (GHS-R) mRNA levels during postnatal development in male and female rats.
J. Neuroendocrinol., Apr;11(4):299-306 (1999)
Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels.
Endocrinology., Aug;140(8):3581-6 (1999)
Isolated familial somatotropinomas: establishment of linkage to chromosome 11q13.1-11q13.3 and evidence for a potential second locus at chromosome 2p16-12.
J. Clin. Endocrinol. Metab., Feb;85(2):707-14 (2000)